Allergy Immunotherapy Market Size (2023-2031) Share, Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports

Newark, New Castle, USA, May 16, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for allergy immunotherapy in 2022 to be worth US$ 2.42 billion. It is expected to expand at a revenue CAGR of 8.4% to reach US$ 5.02 billion by 2031.

Analysis of the global market for allergy immunotherapy indicates that during the forecast period, revenue share is likely to increase significantly. Allergy immunotherapy, commonly known as allergy injections, is a treatment for allergic responses that includes exposing a person too tiny, progressively increasing amounts of an allergen. 

Key Takeaways: 

• The increasing number of allergies worldwide is driving the market revenue share.
• The rising demand for personalized and targeted allergy treatments is driving the market demand.
• The development of new and innovative allergy immunotherapy products is increasing the market revenue growth rapidly.

Get a Free Sample Research Report: https://www.growthplusreports.com/inquiry/request-sample/allergy-immunotherapy-market/8903

                                           Allergy Immunotherapy Market Scope

Recent Development in the Allergy Immunotherapy Market: 

• In July 2022, Positive findings on the substantial effect of sublingual liquid allergen immunotherapy (AIT) on the development and worsening of asthma in patients with allergic rhinitis were presented by a worldwide healthcare company named Stallergenes Greer.
• In March 2022, Phase 2 clinical trials for PVX108, a novel immunotherapy for the treatment of peanut allergy, have started, according to a statement from Aravax Pty Ltd.

Competitive Landscape

A list of the prominent players operating in the global market for allergy immunotherapy includes: 

• Merck KGaA
• Stallergenes Greer plc
• Allergy Therapeutics PLC
• Jubilant Pharma
• DBV Technologies SA

Market Drivers and Restraints: 

The global allergy immunotherapy market revenue is driven by the rising prevalence of allergies worldwide, there is a growing need for efficient allergy therapies, and both patients and healthcare professionals are becoming more aware of the advantages of allergy immunotherapy.

However, the market will also face challenges related to patient adherence to treatment because of the frequent dosage of injection required, which can be expensive and potentially cause side effects.  

Market Segmentation: 

• Based on allergy type, the global allergy immunotherapy market is segmented into allergic rhinitis, allergic asthma, and others. 
• Based on treatment type, the global allergy immunotherapy market is segmented into Sublingual Immunotherapy (SLIT) and Subcutaneous Immunotherapy (SCIT).
• Based on the distribution channel, the global allergy immunotherapy market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/allergy-immunotherapy-market/8903

Segmentation By Allergy Type

Based on the allergy type, the sublingual immunotherapy (SLIT) segment dominates the global allergy immunotherapy market with the largest revenue share. This large share of revenue is due to the FDA approval that SLIT medications have got and are now extensively offered in the United States.

Regional Growth Dynamics

The region with the greatest revenue share in the worldwide market for allergy immunotherapy is Europe because of the significant presence of leading market competitors and the rise in the number of allergy drops that have received regional approval and are expanding their market exponentially.

Report Coverage 

Growth Plus Reports conducted extensive research on the world market for allergy immunotherapy. We thoroughly studied the basic market traits, important investment zones, regional growth analytics, ten ears of revenue projections, rival market participants, and mergers and acquisitions.

 Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3.  Opportunities
5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET - ANALYSIS & FORECAST, BY ALLERGY TYPE
   1. Allergic Rhinitis
   2. Allergic Asthma
   3. Others
6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET - ANALYSIS & FORECAST, BY TREATMENT TYPE
   1. Sublingual Immunotherapy (SLIT)
   2. Subcutaneous Immunotherapy (SCIT)
7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
   1.  Hospital Pharmacies
   2. Retail Pharmacies
   3. Others

ALLERGY IMMUNOTHERAPY MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8903

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Laboratory Balances and Scales Market by Type (Laboratory Balances, Laboratory Scales), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) – Global Outlook & Forecast 2023-2031

Mesenchymal Stem Cells Market by Products & Services (Product [Workflow Type and Product Type] and Services), Type (Autologous, Allogenic), Indication (Bone and Cartilage Repair, Cardiovascular Diseases), Application (Disease Modelling, Drug Development & Discovery) – Global Outlook & Forecast 2023-2031

Examination Tables Market by Product Type (General Examination Table and Special Examination Table), Source Type (Powered and Manual), End User (Hospitals, Clinics) – Global Outlook & Forecast 2023-2031

Communicable Diseases Treatment Market by Disease (Malaria, HIV, Influenza), Treatment (Vaccines, Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Insect Cell Line Market by Product Type (Sf9, High Five), Application (Biopharmaceutical Manufacturing, Cytogenetic), End User (Pharmaceutical Industry, Research Laboratories) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020".